FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Cannabis Research Quality Guidance

[ Price : $8.95]

FDA issues a draft guidance on quality considerations for clinical research related to developing drugs containing cannabis or can...

New COA Grant Funding Opportunity

[ Price : $8.95]

FDA offers a second funding opportunity to develop core sets of clinical outcome assessments for four areas.

FDA Not Cutting Vaccine Standards: Companies

[ Price : $8.95]

Drug company executives try to reassure a House committee that FDA will not lower its standards to approve a Covid-19 vaccine.

FDA Approves Boston Scientific Watchman FLX

[ Price : $8.95]

FDA approves Boston Scientifics Watchman FLX left atrial appendage closure device.

HCT/P Manipulation and Homologous Use Guidance

[ Price : $8.95]

FDA issues a guidance with its current thinking on the regulatory criteria for human cells, tissue, and cellular and tissue-based ...

Paige Digital Pathology Viewer Cleared

[ Price : $8.95]

FDA clears a Paige 510(k) for the FullFocus, a digital pathology image viewer for the purpose of primary diagnosis.

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes Centurion Medical Products, Signa SA de CV facility and Stason Phar...

CGMP Violations at Stason Pharmaceuticals

[ Price : $8.95]

FDA warns Stason Pharmaceuticals about CGMP violations in its production of finished drugs.

Enforcement Discretion Extended on Regenerative Therapies

[ Price : $8.95]

FDA extends by six months its enforcement discretion policy for certain human cell, tissue, and cellular and tissue-based products...

FDA Tightening Internal Lab Safety

[ Price : $8.95]

FDA says it is currently reviewing its internal laboratory safety program to align with ongoing, shifting, and future priorities.